Delivery Order SPE2DB24D1021-SPE2DB25FEZGM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,564.37 to supply Botox 200 unit vials, with an ultimate completion date of August 20, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,613.60 to AmerisourceBergen Drug Corp for the supply of BOTOX 100 Unit Vials. This competitively awarded, firm fixed-price contract has a completion date of August 22, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's existing federal contract vehicle with DLA Troop Support Medical. This delivery order falls...
- The Defense Logistics Agency awarded a $10,257.48 delivery order to AmerisourceBergen Drug Corp for BOTOX 200 Unit Vials on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,419.20 for 200-unit vials of BOTOX on July 21, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX, valued at $3,419.20, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and is being fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $7,227.00 to AmerisourceBergen Drug Corp for the supply of Botox 200 unit vials, with an ultimate completion date of August 25, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,273.95 to AmerisourceBergen Drug Corp for the supply of BOTOX 200 Unit Vials. This firm fixed-price, competitively awarded delivery order has an ultimate completion date of August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of BOTOX 100 unit vials with a ceiling value of $1,722.72. This firm fixed price delivery order represents a non-set-aside competitive award with an ultimate completion date of August 25, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $12,045.00 for the supply of 200-unit vials of BOTOX under a Firm Fixed Price contract with the Defense Department's Medical Supply Chain. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of August 22, 2025. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government, with performance taking...
- The Defense Logistics Agency awarded a $15,056.25 delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Botox on August 4, 2025, with an ultimate completion date of August 25, 2025. This competitive award utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken,...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEZGMDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $4,306.80 delivery order on August 5, 2025, for BOTOX 100 Unit Vials, with an ultimate completion date of August 26, 2025. This firm fixed-price contract is unclassified as a set-aside and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply framework with the federal government. The product will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and a significant portion of its pharmaceutical distribution operations. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support Defense Health Agency operations and other government healthcare systems. AmerisourceBergen was competitively selected for this award and continues to serve as a critical pharmaceutical distributor for federal medical procurement needs, demonstrating capability to meet diverse military and veteran healthcare supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 8/5/25 |